VIDEO: Pediatrics? There's an app for that!

Article

Check out the new and improved iPad app for Contemporary Pediatrics! The app features tons of interactive content and a better way to view our magazine. All issues are completely free!

Click here to download the app.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Infectious Insights | Image Credit: Contemporary Pediatrics
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Related Content
Tyra Bryant-Stephens, MD talks asthma reminders ahead of school year

Tyra Bryant-Stephens, MD talks asthma reminders ahead of school year

Tyra Bryant-Stephens, MD
July 24th 2025
Article

Tyra Bryant-Stephens encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
HHS to remove thimerosal from all influenza vaccines in the US | Image Credit: © JJHVEPhoto - © JHVEPhoto - stock.adobe.com.

HHS to remove thimerosal from all influenza vaccines in the US

Joshua Fitch, Senior Editor
July 24th 2025
Article

Secretary Robert F. Kennedy, Jr. this week signed the ACIP's recommendation to remove the mercury-based preservative from all influenza vaccines.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA grants fast track designation to SGT-501 gene therapy for CPVT | Image credit: Contemporary Pediatrics

FDA grants fast track designation to SGT-501 gene therapy for CPVT

Joshua Fitch, Senior Editor
July 23rd 2025
Article

Solid Biosciences is planning a phase 1b clinical trial of SGT-501 to treat the catecholaminergic polymorphic ventricular tachycardia heart condition.

Nirsevimab demonstrates high effectiveness against RSV in healthy term infants | Image Credit: © zilvergolf - stock.adobe.com.

Nirsevimab demonstrates high effectiveness against RSV in healthy term infants

Morgan Ebert, Managing Editor
July 23rd 2025
Article

Nirsevimab reduced RSV-related illness by up to 98% and lowered hospitalizations and health care use among healthy term infants in a real-world study.

© 2025 MJH Life Sciences

All rights reserved.